Stockscreener 앱 받기
1.09
3.54%
-0.04
시간 외 거래:
1.06
-0.03
-2.75%
전일 마감가:
$1.13
열려 있는:
$1.11
하루 거래량:
16,523
Relative Volume:
0.24
시가총액:
$15.02M
수익:
-
순이익/손실:
$-9.67M
주가수익비율:
-1.165
EPS:
-0.9356
순현금흐름:
$-9.36M
1주 성능:
+7.92%
1개월 성능:
+11.22%
6개월 성능:
-18.05%
1년 성능:
-28.76%
1일 변동 폭
$1.07
$1.11
1주일 범위
$1.005
$1.14
52주 변동 폭
$0.8588
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
명칭
Cocrystal Pharma Inc
전화
(786) 459-1831
주소
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.09 | 15.58M | 0 | -9.67M | -9.36M | -0.9356 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-07-08 | 개시 | H.C. Wainwright | Buy |
Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스
Aug Levels: Can Cocrystal Pharma Inc keep up with sector leaders2026 Update & High Conviction Buy Zone Alerts - baoquankhu1.vn
Cocrystal begins dosing patients in norovirus challenge study - Investing.com Nigeria
Cocrystal Pharma, Inc. Announces Passing of Board Member Dr. Anthony Japour in March 2026 9 - Minichart
Cocrystal Pharma Announces Passing of Board Member Japour - TipRanks
Cocrystal Pharma (COCP) reports death of board director Japour - Stock Titan
Why is Cocrystal Pharma Inc stock going up2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
COCP|Cocrystal Pharma Inc|Price:1.030|Chg%:-0.03 - TradingKey
Cocrystal begins dosing patients in norovirus challenge study By Investing.com - Investing.com South Africa
Can Cocrystal Pharma Inc keep up with sector leadersWall Street Watch & Real-Time Buy Signal Notifications - baoquankhu1.vn
Cocrystal Pharma Doses First Subjects in Phase 1b Trial of CDI-988 Oral Antiviral for Norovirus Prevention and Treatment - Minichart
First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment - Bitget
Cocrystal Pharma announces first subjects dosed in Phase 1b study of CDI-988 - TipRanks
Cocrystal Pharma (COCP) Begins Phase 1b Study for Norovirus Trea - GuruFocus
Cocrystal Initiates Phase 1b Norovirus Antiviral Challenge Study - TipRanks
CDI-988 norovirus challenge trial begins at Cocrystal Pharma (NASDAQ: COCP) - Stock Titan
First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment - GlobeNewswire
First norovirus antiviral trial takes on $60B global cost - Stock Titan
Is Cocrystal Pharma Inc. stock a buy in volatile markets2026 Key Highlights & Weekly Chart Analysis and Trade Guides - Naître et grandir
OMEX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MGIH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
COCP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Influenza Clinical Trial Pipeline Gains Momentum: 120+ - openPR.com
Aug Catalysts: Should value investors consider CCNEPMarket Trend Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Trust linked to Phillip Frost adds 20K Cocrystal (COCP) shares - Stock Titan
COCP: CDI-988 Data to be Presented at ICAR 2026 - Zacks Small Cap Research
Gains Recap: Why is Cocrystal Pharma Inc stock going upTrade Entry Report & Fast Entry High Yield Tips - baoquankhu1.vn
Winners Losers: Why is Cocrystal Pharma Inc stock going upJuly 2025 Trends & Growth Focused Stock Pick Reports - baoquankhu1.vn
Can Cocrystal Pharma Inc. stock sustain institutional interestWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Why ALRM stock attracts high net worth investorsDividend Hike & Daily Momentum Trading Reports - mfd.ru
Is Cocrystal Pharma Inc. stock risky to hold nowJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - mfd.ru
Investment Report: Can Cocrystal Pharma Inc ride the EV waveJuly 2025 PreEarnings & High Return Stock Watch Alerts - baoquankhu1.vn
Cocrystal Highlights CDI-988 Norovirus Data at ICAR 2026 - TipRanks
Norovirus drug CDI-988 to be presented at ICAR2026 by Cocrystal (NASDAQ: COCP) - Stock Titan
Alta Equipment Group Announces Date of Fourth Quarter and Full Year 2025 Financial Results Release, Conference Call and Webcast - Bitget
CareCloud to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026 - Bitget
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor - GlobeNewswire
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026 - Bitget
Will High Tide Inc. stock outperform growth indexesWeekly Investment Recap & Consistent Growth Stock Picks - mfd.ru
Will HNGE stock profit from automation waveEarnings Recap Report & Capital Protection Trade Alerts - mfd.ru
Why Cocrystal Pharma Inc. stock is seen as undervaluedJuly 2025 Reactions & Reliable Volume Spike Trade Alerts - mfd.ru
COCP Should I Buy - Intellectia AI
COCP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why Cocrystal Pharma Inc. stock is rated strong buyJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - mfd.ru
Is Cocrystal Pharma Inc. benefiting from innovation trendsTrade Analysis Report & Safe Entry Zone Tips - mfd.ru
Why IGTR stock attracts HNW investorsJuly 2025 Outlook & AI Powered Market Trend Analysis - mfd.ru
Market Catalysts: Is Cocrystal Pharma Inc benefiting from innovation trendsIPO Watch & Safe Swing Trade Setup Alerts - baoquankhu1.vn
How cyclical is Cocrystal Pharma Inc.’s revenue streamPortfolio Gains Report & Smart Investment Allocation Insights - mfd.ru
Returns Recap: Can Cocrystal Pharma Inc keep up with sector leadersMarket Sentiment Report & AI Enhanced Execution Alerts - baoquankhu1.vn
What’s the outlook for Cocrystal Pharma Inc.’s sectorTrade Signal Summary & Proven Capital Preservation Methods - mfd.ru
Jobs Data: Can Cocrystal Pharma Inc ride the EV waveMarket Growth Summary & Real-Time Stock Movement Alerts - baoquankhu1.vn
Will Cocrystal Pharma Inc. stock recover after earningsTrade Risk Assessment & Capital Protection Trading Alerts - mfd.ru
Cocrystal Pharma Inc (COCP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):